logo

Canadian News

Share

Canadian stocks may creep higher on Thursday, extending this week's gains amid a rally in crude oil prices. Crude oil has surged near $70 a barrel to its highest price since 2014. A drop in U.S. oil inventories was the latest impetus for the advance. Meanwhile, Kinder Morgan admits that its planned...

siga-spotlight-041918.jpg Shares of SIGA Technologies Inc. (SIGA) are up nearly 30 percent year-to-date while the iShares NASDAQ Biotechnology Index (ETF)(IBB) has returned a mere 0.5% during the same period.

The Australian dollar climbed against its major counterparts in the Asian session on Thursday, erasing its early losses, as optimism about global economic growth and strong corporate earnings results boosted investor sentiment. Oil held steady near 2014-highs after reports that top oil exporter Saudi...

pharma-041318.jpg Today's Daily Dose brings you news about an agreement between Pfenex and China NT Pharma; Bristol-Myers' near-term regulatory catalyst; Eloxx Pharma's progress with cystic fibrosis drug candidate and FDA clearance of Cantel Medical's ADVANTAGE PLUS Pass-Thru automated endoscope reprocessor.

pharma-041618.jpg The following are some of today's top gainers in the pharma/biotech sector.

Canadian stocks rose Wednesday after the Bank of Canada held steady on interest rates. "There is a sense that, almost by law of gravity, interest rates will move somewhat higher over time -- but again, the pace is a significant question mark for us given the data," said BoC governor Stephen Poloz. The...

The Canadian stock market is rallying higher in early trade Wednesday. Energy and gold stocks are driving the market higher this morning as commodity prices climb. Crude oil prices have jumped to their highest level in three years due to falling U.S. crude inventories. As expected, the Bank of Canada...

The Canadian dollar declined against its major counterparts in the New York session on Wednesday, after the Bank of Canada kept its benchmark rate unchanged, while saying that it remained "cautious with respect to future policy adjustments." The BoC kept its key rate unchanged at 1.25 percent, in...

olgaints-lawsuit-041818.jpg Two Colorado counties and the City of Boulder have filed a lawsuit against Canada-based Suncor Energy Inc. and U.S. giant Exxon Mobil Corp. for the "substantial role" they played in causing and contributing to climate change-related damage to their communities. The communities of Boulder County, San Miguel County and the City of Boulder filed the lawsuit in a U.S. district court.

As expected, the Bank of Canada kept benchmark rate unchanged at 1.25 percent. The loonie dropped against its major counterparts after the decision. The loonie was trading at 1.2597 against the greenback, 85.15 against the yen, 1.5596 against the euro and 0.9781 against the aussie around 10:01 am ET.

At 10:00 am ET Wednesday, the Bank of Canada announces decision on interest rates. Economists expect the bank to maintain benchmark rate at 1.25 percent. Ahead of the decision, the loonie traded mixed against its major counterparts. While the loonie rose against the euro, yen and the greenback, it...

Canadian stocks may rise Wednesday morning, with energy stocks in focus after crude oil futures rebounded sharply. However, markets may be skittish ahead of this morning's Bank of Canada interest rate decision. While no change is expected, the BoC is expected to signal additional rate hikes are...

moodys-blockchain-041818.jpg A new report by global rating agency Moody's says Blockchain technology has mixed credit implications for global banking systems. While the technology has the potential to significantly reduce the costs and time involved in cross-border banking transactions and increase banks' efficiency, it could put pressure on their fees and commissions, Moody's Investors Service said in a report. Swiss banks

pharma-041618.jpg Today's Daily Dose brings you news about Arcus' phase I trial data of AB928; FDA briefing documents related to GW Pharma's Epidiolex; STELLAR results of Novocure and FDA approval of Rigel's ITP drug and Ultragenyx Pharma's X-linked hypophosphatemia drug.

pharma-up1-041718.jpg The following are some of today's top gainers in the pharma/biotech sector.

Follow RTT